These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2497657)
1. Effects of cholestatic hepatic disease and chronic renal failure on alfentanil pharmacokinetics in children. Davis PJ; Stiller RL; Cook DR; Brandom BW; Davis JE; Scierka AM Anesth Analg; 1989 May; 68(5):579-83. PubMed ID: 2497657 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of sufentanil in adolescent patients with chronic renal failure. Davis PJ; Stiller RL; Cook DR; Brandom BW; Davin-Robinson KA Anesth Analg; 1988 Mar; 67(3):268-71. PubMed ID: 2964213 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of alfentanil in chronic renal failure. Chauvin M; Lebrault C; Levron JC; Duvaldestin P Anesth Analg; 1987 Jan; 66(1):53-6. PubMed ID: 3099599 [TBL] [Abstract][Full Text] [Related]
4. Effects of long-term drugs on alfentanil clearance in patients undergoing renal transplantation. Koehntop DE; Noormohamed SE; Fletcher CV Pharmacotherapy; 1994; 14(5):592-9. PubMed ID: 7997393 [TBL] [Abstract][Full Text] [Related]
5. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis. De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of fentanyl in children with renal disease. Koren G; Crean P; Goresky GV; Klein J; MacLeod SM Res Commun Chem Pathol Pharmacol; 1984 Dec; 46(3):371-9. PubMed ID: 6096939 [TBL] [Abstract][Full Text] [Related]
7. Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. George J; Murray M; Byth K; Farrell GC Hepatology; 1995 Jan; 21(1):120-8. PubMed ID: 7806144 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of alfentanil in children undergoing surgery. Roure P; Jean N; Leclerc AC; Cabanel N; Levron JC; Duvaldestin P Br J Anaesth; 1987 Nov; 59(11):1437-40. PubMed ID: 3120765 [TBL] [Abstract][Full Text] [Related]
9. The clinical pharmacology of alfentanil. Stanski DR Eur J Anaesthesiol Suppl; 1987; 1():3-11. PubMed ID: 3126052 [TBL] [Abstract][Full Text] [Related]
10. Renal failure and dialysis therapy in children with hepatic failure in the perioperative period of orthotopic liver transplantation. Ellis D; Avner ED Clin Nephrol; 1986 Jun; 25(6):295-303. PubMed ID: 3524924 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of fentanyl and alfentanil in ambulatory anesthesia]. Schoeffler P; Dissait F; Fenies V; Forestier B; Brenas F Cah Anesthesiol; 1987; 35(2):87-92. PubMed ID: 3111649 [TBL] [Abstract][Full Text] [Related]
12. A clinical trial of alfentanil as an adjuvant for short anaesthetic procedures. Hull CJ; Jacobson L Br J Anaesth; 1983; 55 Suppl 2():173S-178S. PubMed ID: 6418190 [TBL] [Abstract][Full Text] [Related]
13. Consequences of renal insufficiency on the hepatic clearance of some drugs. Balant LP; Dayer P; Fabre J Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317 [TBL] [Abstract][Full Text] [Related]
14. Sufentanil pharmacokinetics in patients with cirrhosis. Chauvin M; Ferrier C; Haberer JP; Spielvogel C; Lebrault C; Levron JC; Duvaldestin P Anesth Analg; 1989 Jan; 68(1):1-4. PubMed ID: 2521279 [TBL] [Abstract][Full Text] [Related]
15. The influence of hepatic plasma flow on alfentanil plasma concentration plateaus achieved with an infusion model in humans: measurement of alfentanil hepatic extraction coefficient. Chauvin M; Bonnet F; Montembault C; Levron JC; Viars P Anesth Analg; 1986 Oct; 65(10):999-1003. PubMed ID: 2875679 [TBL] [Abstract][Full Text] [Related]
16. Sufentanil pharmacokinetics in pediatric cardiovascular patients. Greeley WJ; de Bruijn NP; Davis DP Anesth Analg; 1987 Nov; 66(11):1067-72. PubMed ID: 2959170 [TBL] [Abstract][Full Text] [Related]